You searched for united kingdom - Page 47 of 55

More News! 10 Oct 2022

RadioMedix announces a $40 million series A financing for targeted alpha therapy platform

…developed by Dr. Delpassand and his team should significantly impact cancer treatments globally. Portland and RadioMedix have aligned their complementary capabilities and are united by a commitment to help others.”…

October 10, 2022 - 3 minutesmins - By Liza Laws

In Depth 18 Mar 2024

Will the US biotech funding surge trigger a renaissance in the global biotech industry?

In recent months, the United States has witnessed a remarkable resurgence in biotech investments, marking a significant turnaround from the preceding challenges faced by the sector. This revival is characterized…

March 18, 2024 - 10 minutesmins - By Jules Adam

News and Trends 8 Oct 2025

Top biotech deals in September 2025

…developer Enlaza Therapeutics have united to develop T-cell engagers as well as a new type of therapy called war-lock drug conjugates, a term coined by Enlaza. These drugs differ from…

October 8, 2025 - 7 minutesmins - By Roohi Mariam Peter

In Depth 24 Jan 2025

Why are there only 20 cell and gene therapies in Europe?

…pointed out that reports by the Alliance for Regenerative Medicine highlight a stark funding disparity between Europe and the United States for cell and gene therapy (CGT) companies. “Despite Europe…

January 24, 2025 - 9 minutesmins - By Jules Adam

Opinion 28 Feb 2023

Life changing treatments for rare disease – a beacon of hope

…1983 in the United States, which revolutionized the industry overnight. This legislation was brought in following recent medical advances to deliberately incentivize the pharmaceutical industry to invest in the development…

February 28, 2023 - 6 minutesmins - By External Contributor

News and Trends 21 Dec 2022

Poolbeg identifies new potential drug candidates for RSV infections

…past few months, RSV has been sending children to hospital at alarming rates in the United States and Europe. As pediatric units fill beyond capacity, and our healthcare systems contend…

December 21, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 10 Nov 2016

This has been the Worst Financial Year for Biotech in a Decade

A presentation on the financial state of biotech kicked off BIO-Europe in Cologne this week. The hostile American political climate has done some damage. There’s a political storm brewing across…

November 10, 2016 - 4 minutesmins - By Evelyn Warner

News and Trends 11 Jul 2022

Financing round of $21M completed for drug to treat autoimmune diseases

…rights of CID-103 in autoimmune indications in the United States. CASI also has the co-commercial rights in the autoimmune-derived hematology indications for CID-103 in China, but is not obligated to co-commercialize those…

July 11, 2022 - 3 minutesmins - By Liza Laws

News and Trends 10 Nov 2022

Promising drug candidate discovered for prevention of type 1 diabetes

…TYK2 inhibitor. This drug molecule has already been approved in the United States for the treatment of psoriasis,” Otonkoski notes. According to Otonkoski, the effect of TYK2 inhibitors in the…

November 10, 2022 - 3 minutesmins - By Jim Cornall

Best in Biotech 5 Mar 2025

Seven biotech companies keeping Taiwan dynamic in 2025

…precision medicine, immunotherapy, and drug development. While Taiwan does not compete with global biotech behemoths like the United States or Europe, it benefits from government support and a growing research…

March 5, 2025 - 8 minutesmins - By Jules Adam

News and Trends 26 Aug 2022

Beyond Biotech podcast 11: Ilya Pharma, IRB Barcelona, Krystal Biotech, Phase Genomics

…to start a clinical trial for cystic fibrosis after the United States Food and Drug Administration (FDA) accepted its investigational new drug (IND) application. The gene therapy company will be…

August 26, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 10 Nov 2022

Parthenon and ImaginAb enter into license and supply agreement for anti-cancer therapies

…its investigational CD8 ImmunoPET technology to Parthenon Therapeutics for use in the clinical development of PRTH-101 at clinical trial sites across the United States. Initially, Parthenon Therapeutics will investigate CD8…

November 10, 2022 - 4 minutesmins - By Liza Laws

Knowledge hub

Categories

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: united kingdom

RadioMedix announces a $40 million series A financing for targeted alpha therapy platform

Will the US biotech funding surge trigger a renaissance in the global biotech industry?

Top biotech deals in September 2025

Why are there only 20 cell and gene therapies in Europe?

Life changing treatments for rare disease – a beacon of hope

Poolbeg identifies new potential drug candidates for RSV infections

This has been the Worst Financial Year for Biotech in a Decade

Financing round of $21M completed for drug to treat autoimmune diseases

Promising drug candidate discovered for prevention of type 1 diabetes

Seven biotech companies keeping Taiwan dynamic in 2025

Beyond Biotech podcast 11: Ilya Pharma, IRB Barcelona, Krystal Biotech, Phase Genomics

Parthenon and ImaginAb enter into license and supply agreement for anti-cancer therapies

Subscribe to our newsletter to get the latest biotech news!

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!